| Date Filed | Type | Description |
| 10/02/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 05/08/2023 |
SC 13D/A
| Casdin Capital, LLC reports a 4.8% stake in Absci Corporation |
| 03/20/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/13/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/10/2023 |
SC 13G/A
| Casdin Capital, LLC reports a 9% stake in MaxCyte, Inc. |
| 12/07/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/29/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/28/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/11/2022 |
SC 13D/A
| Casdin Capital, LLC reports a 5.5% stake in Century Therapeutics, Inc. |
| 07/20/2022 |
SC 13D/A
| Casdin Capital, LLC reports a 8.3% stake in Absci Corporation |
| 04/08/2022 |
SC 13D
| Casdin Capital, LLC reports a 32.7% stake in STANDARD BIOTOOLS INC. |
| 02/14/2022 |
SC 13G/A
| Casdin Capital, LLC reports a 6.5% stake in Verve Therapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| Casdin Capital, LLC reports a 6.6% stake in Magenta Therapeutics, Inc. |
| 02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2022 |
SC 13G/A
| Casdin Capital, LLC reports a 5.4% stake in Invitae Corporation |
| 08/19/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 08/09/2021 |
SC 13D
| Casdin Capital, LLC reports a 8.7% stake in Tenaya Therapeutics, Inc. |
| 08/03/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 07/29/2021 |
SC 13D
| Casdin Capital, LLC reports a 5.9% stake in Century Therapeutics, Inc. |
| 07/29/2021 |
SC 13D
| Casdin Capital, LLC reports a 8.5% stake in Absci Corporation |
| 06/23/2021 |
SC 13G
| Casdin Capital, LLC reports a 6.6% stake in Verve Therapeutics, Inc. |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2021 |
SC 13G/A
| Casdin Capital, LLC reports a 6.4% stake in Invitae Corporation |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/27/2020 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 06/01/2020 |
SC 13G
| Casdin Capital, LLC reports a 7.9% stake in Dermtech, Inc. |
| 05/18/2020 |
SC 13D/A
| Casdin Capital, LLC reports a 4.1% stake in GenMark Diagnostics, Inc. |
| 04/07/2020 |
SC 13G
| Casdin Capital, LLC reports a 7.7% stake in Invitae Corporation |
| 02/20/2020 |
SC 13G
| Casdin Capital, LLC reports a 5.3% stake in Fulcrum Therapeutics, Inc. |
| 02/07/2020 |
SC 13D/A
| Casdin Capital, LLC reports a 5.8% stake in GenMark Diagnostics, Inc. |
| 02/06/2020 |
SC 13G/A
| Casdin Capital, LLC reports a 12.1% stake in BioLife Solutions, Inc. |
|